What are the recommended medical and surgical management options for endometriosis and adenomyosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Endometriosis and Adenomyosis

For endometriosis-associated pain, start with oral contraceptives or progestins (levonorgestrel IUD or depot medroxyprogesterone) as first-line medical therapy, reserving surgery for severe disease, fertility concerns, or medical treatment failure. 1

Medical Management Framework

Endometriosis Pain Management

First-line options (equally effective and lower cost):

  • Combined oral contraceptives
  • Progestins: levonorgestrel intrauterine system or depot medroxyprogesterone acetate 1
  • NSAIDs for symptomatic relief 1

Second-line options (reserve for first-line failures):

  • GnRH agonists for ≥3 months 1
  • Danazol for ≥6 months 1
  • Critical caveat: When using GnRH agonists, always add add-back therapy (estrogen-progestin or progestin alone) to prevent bone mineral loss without compromising pain relief 1

Adenomyosis Medical Management

  • Levonorgestrel intrauterine system (first-line for heavy menstrual bleeding)
  • Dienogest or other progestins
  • Combined oral contraceptives
  • Tranexamic acid (for bleeding only)
  • GnRH analogues 2

Important limitation: No medical therapy eradicates endometriosis or adenomyosis lesions—medications only temporize symptoms and require ongoing use 1, 3

Surgical Management Algorithm

When Surgery is Indicated

Absolute indications:

  • Severe/deep infiltrating endometriosis where medical treatment alone is insufficient 1
  • Desire for pregnancy (infertility concerns) 1
  • Anatomic distortion causing organ damage 4
  • Suspicious lesions requiring histologic diagnosis 1

Relative indications:

  • Medical therapy failure or intolerable side effects
  • Patient preference after informed consent regarding risks

Surgical Approach by Disease Type

Endometriosis:

  • Laparoscopic excision by experienced surgeon at specialized endometriosis center 5
  • Preoperative imaging (transvaginal ultrasound or MRI) is essential for surgical planning and reduces incomplete surgeries 5
  • Critical warning: Surgery provides significant pain reduction in first 6 months, but 44% experience symptom recurrence within 1 year 1

Adenomyosis:

  • Hysterectomy remains the only definitive cure 6, 2
  • Conservative options for fertility preservation:
    • Adenomyomectomy/cytoreductive surgery (requires highly experienced surgeon at dedicated center) 6
    • Uterine artery embolization 2, 7
    • Radiofrequency ablation 7
    • High-intensity focused ultrasound 7
    • Major caveat: Conservative surgery carries risk of uterine rupture in subsequent pregnancies 3

Critical Clinical Pitfalls

The Medical vs. Surgical False Dichotomy

The real choice is not between medical treatment OR surgery—it's between medical treatment alone versus surgery PLUS postoperative medical treatment. 4

  • Surgery does not cure endometriosis
  • Without postoperative hormonal suppression, cumulative recurrence rate is 10% per year 4
  • Always plan for long-term postoperative medical therapy after surgical excision

Adenomyosis as Hidden Cause of Treatment Failure

Screen for concurrent adenomyosis before surgery for deep endometriosis, particularly rectovaginal disease. 8

  • Adenomyosis significantly reduces surgical effectiveness for dyspareunia in rectovaginal endometriosis patients 8
  • Patients with isolated rectovaginal endometriosis show greater improvement (VAS 7.34→3.31) compared to those with concurrent adenomyosis (VAS 7.11→5.40) 8
  • Preoperative imaging (transvaginal ultrasound or MRI) should specifically evaluate for adenomyosis 2

Empiric Treatment Considerations

GnRH agonist therapy can be initiated for chronic pelvic pain even without surgical confirmation of endometriosis, provided detailed evaluation excludes other causes 1. This approach is particularly valuable when:

  • Patient refuses surgery
  • Surgical risk is high
  • Diagnostic uncertainty exists but clinical suspicion is strong

Special Population: Asymptomatic Patients

Expectant management is appropriate for asymptomatic endometriosis since the disease course is unpredictable and may spontaneously regress 1. Avoid treating imaging findings in the absence of symptoms.

Fertility Considerations

  • No medical therapy improves fertility outcomes in endometriosis 1
  • Evidence does not support that untreated minimal/mild endometriosis causes infertility 1
  • For fertility goals: proceed directly to assisted reproductive technology or surgical excision rather than prolonged medical suppression
  • Adenomyosis in fertility patients: consider conservative surgery only at expert centers, with full counseling about uterine rupture risk 3

Quality of Life Priority

When symptoms significantly impair daily function:

  • Prioritize rapid symptom control with first-line medical therapy
  • Avoid delaying effective treatment while pursuing definitive diagnosis
  • Consider patient's reproductive goals, age, and symptom severity in treatment selection
  • For severe deep dyspareunia from fibrotic posterior compartment lesions, surgery may be more effective than medical management 4

Post-hysterectomy for endometriosis: Hormone replacement therapy with estrogen is NOT contraindicated after hysterectomy with bilateral salpingo-oophorectomy 1

References

Research

Guideline No. 437: Diagnosis and Management of Adenomyosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2023

Guideline

acr appropriateness criteria® endometriosis.

Journal of the American College of Radiology, 2024

Research

Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal.

Best practice & research. Clinical obstetrics & gynaecology, 2024

Research

Adenomyosis: A potential cause of surgical failure in treating dyspareunia in rectovaginal septum endometriosis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.